Results 171 to 180 of about 80,312 (314)
Advanced strategies for the management of patients with diabetic foot ulcers: a comprehensive review. [PDF]
Kim JM +7 more
europepmc +1 more source
ABSTRACT Myhre syndrome is an ultrarare genetic disease characterized by short stature, distinct craniofacial features, cardiovascular and respiratory fibrosis and stenosis, neurodevelopmental delays, autism, intellectual disability, and hearing loss. The natural history of Myhre syndrome is still not fully understood due to a small patient population ...
Mary K. Young +6 more
wiley +1 more source
The Voice of Cantú: Lower Voice Pitch Is a New Phenotypic Feature of Cantú Syndrome
ABSTRACT Cantú syndrome (CS) is a rare genetic condition caused by pathogenic variants in either ABCC9 or KCNJ8, leading to gain‐of‐function of KATP‐channels. The main clinical features are hypertrichosis and cardiovascular abnormalities. This study investigates the voice characteristics in individuals with CS, an aspect that has received little ...
Lotte Kleinendorst +4 more
wiley +1 more source
Role of Biomarkers in Diabetic Foot Osteomyelitis. [PDF]
Gureh M +4 more
europepmc +1 more source
CORRELATION OF INCREASED FIBRINOGEN & OXIDATIVE STRESS IN PROGNOSIS OF DIABETIC FOOT ULCER
Suvendu Sekhar Acharya +2 more
openalex +1 more source
The experimental type 2 diabetes model in rats induced by streptozotocin and nicotinamide showed that silver nanoparticles synthesized from lemongrass extract modulate blood glucose, water and food intake, and enhance antioxidant enzyme synthesis and weight gains.
Milad Faraji +6 more
wiley +1 more source
Advancing Diabetic Foot Ulcer Care: Focus on the Post-Healing Transition Phase. [PDF]
Shakir K +6 more
europepmc +1 more source
COMPREHENSIVE TREATMENT OF DIABETIC FOOT SYNDROME
M. G. Honchar +6 more
openalex +2 more sources
Objective The objective of this study was to compare clinical features and prognosis of late‐onset neuromyelitis optica spectrum disorder (LO‐NMOSD, onset age ≥60 years) with adult‐onset NMOSD (AO‐NMOSD, onset age 18–59 years), and to provide insights for individualized management in elderly patients.
Ya‐Lan Pu +15 more
wiley +1 more source

